The objectives of this study were to compare the risk of non‐skin cancer in LRRK2 mutation carriers and individuals with iPD, explore the age at which LRRK2 mutation carriers have cancer compared to iPD subjects, and clarify whether certain cancers are more closely associated with the LRRK2 mutation than iPD. Here, LRRK2 is linked to cancer.